Phosphatase activation and kinase inhibition as a novel therapeutic strategy for pancreatic cancer

被引:0
|
作者
Allen-Petersen, Brittany L. [1 ]
Farrell, Amy S. [1 ]
Daniel, Colin J. [1 ]
Wang, Zhiping [1 ]
Lopez, Charles D. [1 ]
Christensen, Dale J. [2 ]
Sheppard, Brett C. [1 ]
Sears, Rosalie C. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Oncotide Pharmaceut, Durham, NC USA
关键词
D O I
10.1158/1538-7445.PANCA2014-A104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A104
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Targeted inhibition of the WEE1 kinase as a novel therapeutic strategy in neuroendocrine neoplasms
    Weindl, Lena
    Atreya, Imke
    Dietrich, Peter
    Neubeck, Sabine
    Neurath, Markus F.
    Pavel, Marianne
    ENDOCRINE-RELATED CANCER, 2021, 28 (09) : 605 - 620
  • [22] Inhibition of metastasis through therapeutic targeting of focal adhesion kinase (FAK) in pancreatic cancer
    Dhani, Neesha C.
    Schwock, Joerg
    Cao, Ping-Jiang M.
    Tsao, Ming-Sound
    Hedley, David W.
    CANCER RESEARCH, 2011, 71
  • [23] Glycogen synthase kinase-3β: a novel therapeutic target for pancreatic cancer
    Ding, Li
    Billadeau, Daniel D.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (05) : 417 - 426
  • [24] Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC)
    Wijnen, Rosa
    Pecoraro, Camilla
    Carbone, Daniela
    Fiuji, Hamid
    Avan, Amir
    Peters, Godefridus J.
    Giovannetti, Elisa
    Diana, Patrizia
    CANCERS, 2021, 13 (17)
  • [25] Dual targeting of protein tyrosine kinase c-Src and protein tyrosine phosphatase SHP-2 is a novel therapeutic strategy that induces potent inhibition of pancreatic cancer cell viability in vitro and tumor progression in vivo
    Gomes, Evan
    Connelly, Sarah F.
    Summy, Justin M.
    CANCER RESEARCH, 2012, 72
  • [26] Autophagy inhibition as a therapeutic strategy in cancer
    Chen, Ning
    Price, Sandy
    Karantza, Vassiliki
    CANCER RESEARCH, 2011, 71
  • [27] Deubiquitinase inhibition as a cancer therapeutic strategy
    D'Arcy, Padraig
    Wang, Xin
    Linder, Stig
    PHARMACOLOGY & THERAPEUTICS, 2015, 147 : 32 - 54
  • [28] Development of a novel therapeutic strategy for pancreatic cancer targeting ANXA8
    Kurogi, Shusaku
    Tsukamoto, Yoshiyuki
    Nakada, Chisato
    Hijiya, Naoki
    CANCER SCIENCE, 2025, 116 : 1211 - 1211
  • [29] Targeting Sema3D in pancreatic cancer: A novel therapeutic strategy
    Murphy, Adrian
    Kleponis, Jennifer
    Rucki, Agnieszka
    Jaffee, Elizabeth M.
    Zheng, Lei
    Foley, Kelly
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] Therapeutic inhibition of nonsense mediated decay as a novel treatment for pancreatic cancer.
    Luo, MD
    Jimeno, A
    Hidalgo, M
    Iacobuzio-Donahue, C
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9142S - 9143S